ABOUT OPTINSIGHT.
Consent is more then a checkbox. It is a communication contract.
We help pharma and life sciences build long-lasting relationships with HCPs in the digital world.
We help pharma and life sciences build long-lasting relationships with HCPs in the digital world. Even in a digital world, relationships are built on trust. This means that your customer data must provide an accurate picture of reality.
Even in a digital world, relationships are built on trust. This means that your customer data must provide an accurate picture of reality.
So what is it that we do exactly?
OptInsight facilitates Pharma, Life sciences and commercial health organisations who want to engage with healthcare professionals . The foundation of this effort is the use of compliant, reliable, and pertinent healthcare professional data, which enables effective communication to increase relevant reach.
Why
Humanizing data, because we care.
We believe that digitization and data are about people, not technology. That is why we help everyone who interacts with HCPs to do so in a human way. When engagement is relevant and respectful, everyone wins.
How
Bringing people and data together in a trusted way.
We bring people and their data together into one truth so that the pharmaceutical company has access to up-to-date data, allowing them to provide the right information back to the HCP.
What
Making digital HCP engagement possible.
OptInsight is a real-time consent and preference Saas solution that orchestrates and automates consent & preference flows. It collects, manages and enriches HCP data and connects seamless with other applications.
Our story
“Our belief is that building trust in a data driven business is about value, personal attention and respect for individual privacy.”
Founded in 2018
The founders of OptInsight came together in 2018.
The start was not only about ideas, but also a solution and business model was born. This was achieved by bringing together state-of-the-art technology, problem solving capabilities , knowledge of compliance and the ambition to build trusted relationships in a digital world.
By the end of 2018, the company was founded with the ambition of bringing people and organizations together in a data driven world.
The DNA of the company comprises of people-centricity, fun, innovation and fast forward thinking.
Trusted by pharma organizations across Europe
50
%
HCP's opted in
60
%
Opt-out to opt-in conversion
30
%
Appointment planning up to 30% on first contact
50
%
Increase of HCP preferences
70
%
HCP records deduplication
“Consent is not a single goal.”
Obtaining consent (opt-in) is not an end in itself, but rather a fundamental requirement for enabling and permitting digital communication. In essence, it establishes an agreement between the doctor and the pharmaceutical company regarding what information can be communicated and under what conditions.
“It must be clear what the HCP receives in return for the use of their personal data.”
The doctor shares their personal data for this purpose and specifies their preferences for the type and manner of communication.
“Consent is the mechanism to agree on the exchange of data and information”
And this mechanism should also provide an option to opt out of the communication relationship or a way to change the way the data is used.
We are delighted to provide you with a detailed overview of our company.
And that’s not all we can help you with. Curious?
Schedule a meeting with us.
Tip: involve your colleagues from other departments within your company. In this way we can instantly answer questions and provide clarity from various points of view.
”We didn’t want to rely on just a ticked box in a CRM system.
OptInsight e-consent solution brings clarity in scattered data, so it’s centralized, all while providing proof of the actual given e-consent. OptInsight is a young company in constant development and with a future outlook, which is refreshing.
Their unique knowledge about and expertise in the sometimes-peculiar pharmaceutical industry is also a big plus, because they understand the brick walls within the industry.
-Director business intelligence UK based Pharma-company-
CLIENT REVIEW
